How Health Insurers Actually Make Money

TL;DR

The financial engine of managed care is shifting rapidly as major insurers utilize vertically integrated service divisions to offset severe margin compression in their core insurance segments. Facing Medicare Advantage and Medicaid funding pressures, these conglomerates are aggressively shedding unprofitable members and exiting markets to protect their bottom lines rather than absorbing the losses. This "price over volume" strategy demonstrates that while public anger focuses on premium collection, the real economic power lies in the internal recycling of healthcare service revenues.

Vertical Integration as a Margin Buffer

Unregulated healthcare services and care delivery arms are now carrying the financial weight of the major managed care conglomerates, shielding them from severe margin compression in their core insurance segments.

"When we get the clinical care right and run the business more efficiently, everything else follows—stronger earnings and better health and experiences for the people we serve." — Jim Rechtin, Humana President and CEO in us-health-insurers-profit-engine-vertical-integration-vs-regulated-margins

These conglomerates have effectively transformed into services-and-pharmacy businesses with an attached insurance front-end that acts primarily as a customer-acquisition funnel. By capturing margin through internal segments like Cigna's Evernorth (which generated 56.6% of Cigna's total segment profits), Elevance's Carelon (which generated 51.4% of Elevance's operating gain), and Humana's CenterWell (which generated 36.2% of Humana's operating profits), parent companies can successfully insulate their consolidated earnings from strict regulatory caps on insurance margins [us-health-insurers-profit-engine-vertical-integration-vs-regulated-margins].

What to watch: Watch whether these integrated services segments can sustain their high margins if federal regulators intensify scrutiny on internal "arm's length" transactions and transfer pricing.

Strategic Retreat and Pricing Discipline

Major managed care organizations are actively sacrificing membership volume in favor of pricing discipline, executing targeted exits from unprofitable Medicaid and Medicare Advantage markets to defend their bottom lines.

"We expect to exit additional Medicaid markets over the next 12 to 18 months, where we do not see a path to sustainable performance." — Gail K. Boudreaux, Elevance Health President and CEO in elevance-health-carelon-vertical-integration-internal-margins

This strategic shift proves that insurers will not absorb the financial impact of government funding cuts or post-pandemic enrollment changes. Instead, they will shrink their footprint—evidenced by UnitedHealthcare contracting its Medicare Advantage membership by 9% [unitedhealth-optum-vertical-integration-medicare-advantage] and Centene letting its Marketplace membership fall by 40.4% [centene-marketplace-risk-adjustment-wakely-catalyst]—leaving states and consumers to bear the consequences of reduced choice, while the insurers maintain thin but disciplined margins like Elevance's 2.1% core insurance segment margin [elevance-health-carelon-vertical-integration-internal-margins].

What to watch: Watch for how state Medicaid agencies respond to these targeted exits and whether they will be forced to adjust their rates to lure back departing national carriers.

What surprised us

• Centene's dramatic 40.4% drop in Marketplace membership turned out to be a massive financial win [[centene-marketplace-risk-adjustment-wakely-catalyst]](/topics/019e89d0-893e-7d00-a5cf-ca1051e66e9d/notes/centene-marketplace-risk-adjustment-wakely-catalyst]. By choosing pricing discipline and risk transfer over volume, Centene drove its Commercial health benefits ratio down to a stellar 79.2% and raised its full-year guidance floor.
• Elevance's Carelon services segment brought in more operating gain ($948 million) than its entire core health benefits insurance business ($896 million) [[elevance-health-carelon-vertical-integration-internal-margins]](/topics/019e89d0-893e-7d00-a5cf-ca1051e66e9d/notes/elevance-health-carelon-vertical-integration-internal-margins]. This stark inversion highlights how completely the traditional insurance model has been eclipsed by internal services.
• Humana was forced to slash its full-year GAAP EPS guidance from "at least $8.36" to "at least $6.52" due to Star Ratings headwinds [[humana-medicare-advantage-margin-compression]](/topics/019e89d0-893e-7d00-a5cf-ca1051e66e9d/notes/humana-medicare-advantage-margin-compression]. This massive cut illustrates the extreme vulnerability of pure-play insurers to federal regulatory metrics compared to their highly diversified peers.

Since last time

• Escalated — Vertical Integration: Previously framed as a mechanism to bypass MLR caps, this is now the primary survival strategy for conglomerates, with service segments effectively "carrying" the company.
• Promoted — Strategic Retreat and Pricing Discipline: This is a new core focus. Insurers are now actively shedding membership to protect margins, a shift from the previous focus on regulatory backlash.
• Disappeared — PBM Legislative and Structural Backlash: The previous focus on the FTC/DOJ probes, generic drug markups, and Cigna’s specific rebate-free pivot is entirely absent from the new briefing.
• Unchanged — None. The narrative focus has shifted entirely to margin preservation and market exits.

Vertical Integration as a Margin Buffer (Escalated)

While our previous update focused on how vertical integration allows companies to "recycle" capital to bypass profit caps, the narrative has shifted: these service divisions are now the primary engine keeping conglomerates profitable as core insurance margins compress.

"When we get the clinical care right and run the business more efficiently, everything else follows—stronger earnings and better health and experiences for the people we serve." — Jim Rechtin, Humana President and CEO in us-health-insurers-profit-engine-vertical-integration-vs-regulated-margins

Conglomerates have pivoted to a model where the insurance front-end acts primarily as a customer-acquisition funnel for their high-margin service arms. These internal segments are now the dominant profit drivers:

• Cigna's Evernorth: Generated 56.6% of total segment profits.
• Elevance's Carelon: Generated 51.4% of operating gain.
• Humana's CenterWell: Generated 36.2% of operating profits.

What to watch: Watch whether these integrated services segments can sustain their high margins if federal regulators intensify scrutiny on internal "arm's length" transactions and transfer pricing.

Strategic Retreat and Pricing Discipline (Promoted)

Insurers are no longer just absorbing regulatory headwinds; they are actively shrinking their footprint to protect their bottom lines. This "price over volume" strategy marks a departure from the previous focus on legislative scrutiny, shifting the focus to how companies are managing market exits.

"We expect to exit additional Medicaid markets over the next 12 to 18 months, where we do not see a path to sustainable performance." — Gail K. Boudreaux, Elevance Health President and CEO in elevance-health-carelon-vertical-integration-internal-margins

The data shows a clear trend of insurers prioritizing margin stability over market share:

• UnitedHealthcare: Contracted Medicare Advantage membership by 9% [unitedhealth-optum-vertical-integration-medicare-advantage].
• Centene: Let Marketplace membership fall by 40.4% [centene-marketplace-risk-adjustment-wakely-catalyst].
• Elevance: Maintaining a disciplined 2.1% core insurance segment margin [elevance-health-carelon-vertical-integration-internal-margins].

What to watch: Watch for how state Medicaid agencies respond to these targeted exits and whether they will be forced to adjust their rates to lure back departing national carriers.

What surprised us

• Centene's dramatic 40.4% drop in Marketplace membership turned out to be a massive financial win [NEW]. By choosing pricing discipline and risk transfer over volume, Centene drove its Commercial health benefits ratio down to a stellar 79.2% and raised its full-year guidance floor.
• Elevance's Carelon services segment brought in more operating gain ($948 million) than its entire core health benefits insurance business ($896 million) [NEW]. This stark inversion highlights how completely the traditional insurance model has been eclipsed by internal services.
• Humana was forced to slash its full-year GAAP EPS guidance from "at least $8.36" to "at least $6.52" due to Star Ratings headwinds [NEW]. This massive cut illustrates the extreme vulnerability of pure-play insurers to federal regulatory metrics compared to their highly diversified peers.

Open threads

• CMS "arm's length" disclosure rules: Dropped from current focus; the briefing now emphasizes the impact of internal margins rather than the regulatory enforcement mechanism.
• DOJ monopolization probe into UnitedHealth: Dropped from current focus; the briefing has shifted entirely to market exit strategies and internal profit generation.